mas. CGH serves as a molecular cytogenetic screen ing test that allows mapping of chromosomal copy number changes on normal metaphase chromo somes (Kallioniemi et al., 1992) . Therefore, tumor cell culture is not required, and archival tissue sections that were formalin fixed and paraffin embedded can be used for analysis (Speicher et al., 1993; Isola et aL, 1994) . This feature of CGH is particularly useful when a phenotype/genotype analysis in solid tumor progression is attempted . We have recently applied CGH to identify chromosomal aberrations that occur during the genesis of cervical carcinomas. T he analysis of DNA extracted from normal cervical epithelium, mild, moderate, and severe dysplasias, and invasive carcinomas (stage I) has shown that the emergence of copy number increases of chromo some arm 3q defines the transition from preinva-
INTRODUCTION
Cervical carcinomas are the second most com mon tumors in women worldwide. T h e tumor incidence shows strong variability, with industrial ized countries having lower morbidity and mortality rates than do developing countries (Pisani et al., 1993) . T his variation is attributable mostly to cyto logic screening programs (Hakama et al., 1986) . Although other factors, such as cigarette smoking, may influence the incidence of cervical cancer, infection with hum an papilloma virus (HPV) is the initiating event for cervical carcinogenesis (IARC, 1995) . It is conceivable, however, that additional, 4 genetic aberrations are required for the multistep process of tumor initiation and progression (Fearon and Vogelstein, 1990; zur Hausen, 1994) . Determi nation of mandatory genetic aberrations for tumor progression would potentially lead to diagnostic predictors. T h e search for recurrent chromosomal aberrations in cervical carcinomas, however, was hampered by technical difficulties in karyotype analysis by means of chromosome banding tech niques (Atkin et al., 1990) . We have therefore used comparative genomic hybridization (CGH) to iden tify recurrent gains and losses in cervical carcino-sive to invasive tumors (Heselmeyer et al., 1996) . In order to explore the relevance of the gain of chromosome arm 3q in advanced stages of tumor progression and to identify additional copy number changes, we have performed CGH on 30 cases of stage lib to IV squamous cell carcinomas of the uterine cervix.
MATERIALS A N D METHODS

Tissue Samples
Thirty tumors were collected at the Karolinska Hospital, Stockholm, Sweden, between 1991 and 1995. All tumors were diagnosed as cervical squa mous cell carcinomas. Patient age and tumor stag ing are presented in Table 1 . T he tumors were staged based on clinical and histologic assessment according to the International Federation of Gynae cology and Obstetrics (FIGO) (Shepherd, 1989) . Consecutive sections were cut from all formalinfixed, paraffin-embedded samples. T he tissue sec tions were used for DNA ploidy measurements (thickness 8 pm), immunohistochemistry (4 pm), and tumor DNA extraction (50 pm). T he last section (4 pm) was stained with hematoxylin-eosin (H&E) for confirmation of the presence of tumor tissue. All tumor samples were obtained before treatment.
D N A Cytometry
DNA content measurements were performed by image cytometry on Fculgen-stained histologic sec tions as described (Auer et al., 1989; Auer et al., 1994) . All DNA values were expressed in relation to the corresponding staining controls, which were given the value 2c, indicating the normal diploid DNA content. Three classes of histograms were obtained: 1) tetraploid cases with a main peak in the 4c region and no cells or only a minor fraction of cells (less than 5%) exceeding 5c; 2) aneuploid/ proliferating tetraploid cases with a peak in the 4c region and a fraction of 5-20% of the cells exceed ing 5c; and 3) aneuploid cases with a main peak around the 4c region and more than 20% of the cells exceeding 5c. Examples of the histograms are shown in Figure 1 .
Immunohistochemistry
Proliferative activity was determined with an antibody (MIB-1) directed against the Ki-67 anti gen. T he antibody distinguishes cells in GO from cells that are in G1-S-G2-M phase of the cell cycle. p21/YVAF-l expression was. analyzed with the WAF-1 antibody (Oncogene Sciences, Uniondale, NY), and TP53 expression was determined with the DO-1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA). Immunohistochemistry was per formed essentially as described (Steinbeck et al., 1995) . T he quantification of the results is presented in Table 1 .
H P V Genotyping
HPV genomes in the purified DNA samples were identified by polymerase chain reaction (PCR), with the MY09-MY11 L I consensus primers used for amplification (Bosch et al., 1995) . We used 25 type-specific probes and one generic HPV probe to diagnose the HPV type in the PCR products (Hildesheim et al., 1994) . p-globin amplification was used as a positive control for evaluation of the adequacy of tumor DNA, C G H CGH was performed according to standard proce dures (Heselmeyer et al., 1996) . Tumor DNA was extracted from sodium isothiocyanate-treated, for malin-fixed tissue sections as described . Nick translation was performed with bio-16-dUTP (tumor DNA) and digoxigenin-11-clUTP (reference DNA, prepared from a karyotypically normal female donor). Five hundred nanograms of each of the labeled genomes was combined and hybridized with an excess of Cot-1 DNA (25 j-ig) to metaphase chromosomes prepared from a karyotypically normal donor. T h e biotin-labeled tumor genome was visualized with avid in conju gated to fluorescein isothiocyanate (FITC) (Vector Laboratories, Burlingame, CA), and the digoxigeninlabeled reference DNA with a mouse anti-digoxin antibody (Sigma, St. Louis, MO), followed by detection with a goat anti-mouse antibody conju gated to tetramethy]rhodamine isothiocyanate (TRITC) (Sigma). Chromosomes were counter stained with DAPI to generate a G-like banding pattern.
Gray scale images of the DAPI counterstain, the FITC-labeled tumor DNA, and the TR ITClabeled reference DNA from at least 8 metaphases from each hybridization were acquired with a cooled CCD camera (CH250, Photometries, Tucson, AZ) connected to a Leica DM RBE microscope equipped with fluorochrome-specific optical filters TR1, TR2, and TR3 (Chroma Technology, Brattlcboro, VT). Quantitative evaluation of the hybridization was achieved with a custom-designed computer pro- *ram, the details of which are described by du images (Fig. 2D ,EX We used average ratio profiles vlanoir et al. (1995) . Average ratio profiles were to identify chromosomal copy number changes in computed as the mean value of at least 8 ratio all cases. 
RESULTS
We recently identified a gain of chromosome arm 3q as a recurrent chromosomal aberration that occurs at the transition from preinvasive to invasive, early-stage cervical carcinomas (Heselmeyer et al., 1996) . We performed the present study to address the question whether gain of 3q is maintained when the tumors progress, and to identify additional chromosomal aberrations that might be required for further progression of cervical carcinomas. We now report the mapping of chromosomal gains and losses in 30 cases of advanced-stage cervical carcino mas. T he clinical data are summarized in Table 1 .
CGH Analysis
Genomic tumor DNA was extracted from 50 pm formalin-fixed, paraffin-embedded tissue sections that were microdissected from representative re gions of the tumor ( Fig. 2A ). An example of the CGH analysis is presented for case 15 as a ratio average ratio profile of 10 metaphases of the same case (Fig. 2D,E ). Average ratio profiles were used for mapping of copy num ber changes in all in stances. Chromosomal aberrations were detected in all 30 cases; the average num ber of chromosomal aberrations per case was 8.2. D espite the high number of chromosomal aberrations, a recurrent and specific pattern emerged in advanced-stage cervical carcinomas: the most frequent copy num ber alteration was a gain of chromosome arm 3q, which occurred in 23 of the 30 cases (77%). In 4 cases, the gain of 3 q was present as a high level copy num ber increase (amplification). T h e consen sus region of 3q amplification was mapped to chromosomal bands 3q26-27. Gain of genetic mate rial was also identified on chromosome arms lq (14/30), 5p (9/30), 6p (8/30), and 2 0 p (7/30). Wholearm amplifications were frequently observed on 5p. Regional high level copy num ber increases (ampli fications) were mapped to chromosomal bands 3q26-27, 9p23-24, llq22-23, and 12pl3. T h e most common chromosomal copy num ber decrease was mapped to chromosome arm 3p (15/30), band 2q36-37 (10/30), 6 q (8/30), 8p (7/30), 4p (7/30), and 13q (8/30). A summary of chromosomal gains and losses is presented in Figure 3 .
HPV Genotyping
T h e presence of HPV genomes was analyzed by PCR in the same D N A as for CGH. Ail samples could be analyzed successfully with a primer for the p-globin gene used as a control. HPV genomes were not detected in 5 cases. Twenty-five tumor samples yielded positive test results. Invariably, the detected HPV belonged to the high-risk group. HPV 16 accounted for 48% of the infections, followed by HPV 45 (6/25). T h e results are summa rized in Table 1 .
D N A Ploidy Measurement
DNA ploidy was measured on consecutive tissue sections by image cytom etry Image cytometry complements the CGH analyses by providing infor mation of the DNA ploidy .that cannot be gained ( from CGH experiments alone. N one of the tumors showed a normal diploid DNA content. Most cases had crude aneuploidy, with either proliferating tetraploid cell populations or highly aneuploid cell populations; more than 2 0 % of the cells exceeded 5c values. T h e results are presented in Table 1 .
Im m unocytochem istry
T h e antibodies MIB-1, which is directed against image of a representative metaphase cell and as an the Ki-67 antigen, D O -1, which reacts with T P 53, TP53 (B) , and p2l/WAF-l (C) of case IS. Immunoreactive nuclei appear dark brown. The tissue was counterstained with H&E, which appears blue. In this case, the proliferative activity was increased in 80% of the cells (A), TP53 expression was negligibly low (<2% ) (B), and p2l/WAF-l immunoreactivity was present in 60% of the cells (C). D: A ratio image of case I 5. Blue indicates a balance between tum or and test genomes, red reflects a loss of genetic material in the tum or D N A, and green shows regions that are gained in the tumor, E: The average ratio profile that was computed on the basis of IÛ ratio images. The three vertical lines on the right side of the chromosome ideograms reflect different values of the fluorescence ratio between tumor and normal DNA. The values are 0.75, I , and i .25 from (eft to right, respectively. Copy number changes are present on 1, 3q, 5p, 6p, 9p, and X (gains) and 3p, 6q, and I 3 (losses). 
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/// Y expression of TP53 in cases 11 (60% of the cells reacting) and 20 (80%) did not affect the expression pattern of WAF-1. Examples of the immunohisto-chemical findings (case 15) are provided in Figure  2A -C. The quantification of the data is summarized in Table 1 .
D IS C U S S IO N
This study summarizes the results of a combined henotype/genotype analysis of 30 cases of aclinced-stage cervical carcinomas. By using CGH as molecular cytogenetic screening test for copy umber changes, we identified a recurrent and age-specific pattern of chromosomal aberrations l these tumors. Proliferation analysis and measurelent of the cellular DNA content revealed that jvanced-stage cervical tumors were highly prolifrative and aneuploid, frequently with stemlines in le tetraploid region. We examined the expression ;atus of TP53 and p21/WAF-l to understand the ivolvement of p53 in the progression of cervical ircinomas. High-risk. HPV types were detected in 3% of the tumors. CGH analysis uncovered a recurrent pattern of iromosomal aberrations in advanced-stage disase. Most commonly, we observed a gain of hiromosome arm 3q (23 of 30 tumors). In 4 cases, lese gains were present as high level copy number lcreases. T he smallest amplicon could be mapped ) chromosomal bands 3q26-27. It is likely that this igion harbors a gene or genes whose gain of .inction is important in cervical carcinogenesis. )ther characteristic copy number increases were lapped to chromosome arm 5p, remarkably often s high level copy number increases, and to chromo-3me arm lq. T he involvement of chromosome arm q was suspected by G-banding analysis (Popescu nd DiPaolo, 1992) . Atkin et al. (1990) have obsrved a marker chromosome in many cervical arcinomas and suggested that it reflects an isochrolosome 4p or 5p. T h e frequent gain of 5p material i our collection of advanced cervical carcinomas uggests that this marker is likely to be derived :om an i(5)(pl0). It is noteworthy in this context tvat Mitra and colleagues (1995) identified loss of eterozygosity (LOH) on chromosome arm 5p in reinvasive lesions. However, the gain of 5p seems 3 be a recurrent event during progression to dvanced-stage carcinomas. Consistent losses, in dicative of chromosomes where tumor suppressor ;enes reside, were mapped to chromosome arms p, 8p, 13q, and 2q. T h e loss of chromosome arm 3p 5 also a frequent finding in LO H studies (Mullokanlov et al., 1996) . Chromosome arm 1 lq showed opy number decreases in 6 cases. LOH studies vith markers for this chromosome arm indicated a ecurrent loss in cervical carcinomas (Srivatsan et 1., 1991) . Twenty-two whole-arm or band-specific amplifications were mapped. Compared to the number of amplifications in small cell lung carcino mas Levin et al, 1995) , aneuploid breast carcinomas (Kallioniemi et al., 1994; , and glioblastomas (Schrock et al., 1994; Kim et al., 1995) , this number is low. T he average number of chromosomal aberrations (ANCA) per case amounts to 8.2. This is similar to the ANCA index established by use of CGH analysis of glioblas tomas, where it is 8.3 (Schrock et al., 1994) , and aneuploid breast carcinomas, where it is 6.8 , indicating a high genetic instability.
We have previously analyzed, by CGH, DNA copy number changes that occur in the progression from normal cervical epithelium to stage I invasive carcinomas (Heselmeyer et al, 1996) . Nine of 10 of the invasive carcinomas exhibited a gain of chromo some arm 3q, whereas this aberration was present in only 1 of 13 severe dysplasias. It is, therefore, obvious that the gain of chromosome arm 3q occurs at the transition from preinvasive to invasive dis ease. T he analysis of 30 cases of advanced-stage carcinomas shows that this particular chromosomal aberration was maintained in the majority of the tumors (77%). However, additional chromosomal changes emerged that include gains of chromosome arms lq and 5p, as well as losses of 2q. T he analyses allow us to identify a stage-specific pattern of chromosomal aberrations, in which 3q gain is an early event that coincides with the progression from preinvasive lesions to stage I invasive carcinomas. T he gains of chromosome arms lq and 5p, however, occur in advanced stages of tumor progression.
T he immunohistochemical pattern in advanced cervical carcinomas can be summarized as follows: TP53 expression is relatively low, and only two cases revealed increased immunoreactivity. p21/WAF~l is generally elevated. This is in sharp contrast to colon carcinomas, where TP53 levels are dramatically increased and immunoreactivity for p21/WAF-l is low . We hypoth esized that the difference in immunophenotype is due to the frequent presence of high-risk HPV in advanced-stage cervical carcinomas. Interestingly, a strikingly similar immunophenotypic response was observed in a series of squamous cell carcinomas of the anal canal, which, like cervical carcinomas, are often associated with HPV infection. Apparently the presence of HPV is not sufficient to inactivate all p53 activity, because p21/WAF-l is still in creased (Heselmeyer et al., in press) . ' The correlation of phenotype/genotype in cervi cal carcinomas can be summarized as follows: HPV infection is present in mildly dysplastic lesions and persists throughout advanced stages. Virtually all I IP Vs in lesions with increased levels of dysplasia belong to the high-risk group. Proliferative activity reaches maximum levels in severely dysplastic lesions and remains elevated during the progression to advanced-stage tumors. The tetraploidization that we observed already in mild dysplasia is replaced by cells with profound aneuploidy (Heselmeyer et al., 1996) . The gain of chromosome arm 3cj is an early event in cervical carcinogenesis and occurs at the transition from pre malign ant lesions to invasive carcinoma, stage I. During pro gression to advanced-stage disease, additional chro mosomal aberrations are acquired, namely, the gain of chromosome arms lq and 5p, as well as the loss of chromosomal bands 2q36-37, The gain of chromo some 3q, however, persists.
